{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:05:03Z","timestamp":1783940703566,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,13]]},"DOI":"10.7759\/cureus.112566","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:10:56Z","timestamp":1783937456000},"source":"Crossref","is-referenced-by-count":0,"title":["Polygenic Risk Scores in Cardiovascular Prevention: Clinical Promise, Implementation Challenges, and Genomic Risk Stewardship"],"prefix":"10.7759","author":[{"given":"Hamsa J","family":"Banjer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100006","article-title":"Returning integrated genomic risk and clinical recommendations: the eMERGE study","volume":"25","author":"Linder JE","year":"2023","unstructured":"Linder JE, Allworth A, Bland HT, et al.. Returning integrated genomic risk and clinical recommendations: the eMERGE study. Genet Med. 2023, 25:100006. 10.1016\/j.gim.2023.100006","journal-title":"Genet Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae649","article-title":"Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: a clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology","volume":"46","author":"Schunkert H","year":"2025","unstructured":"Schunkert H, Di Angelantonio E, Inouye M, et al.. Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease: a clinical consensus statement of the ESC Council on Cardiovascular Genomics, the ESC Cardiovascular Risk Collaboration, and the European Association of Preventive Cardiology. Eur Heart J. 2025, 46:1372-83. 10.1093\/eurheartj\/ehae649","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03243-6","article-title":"Improving reporting standards for polygenic scores in risk prediction studies","volume":"591","author":"Wand H","year":"2021","unstructured":"Wand H, Lambert SA, Tamburro C, et al.. Improving reporting standards for polygenic scores in risk prediction studies. Nature. 2021, 591:211-9. 10.1038\/s41586-021-03243-6","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00638-w","article-title":"Clinical utility of polygenic risk scores for coronary artery disease","volume":"19","author":"Klarin D","year":"2022","unstructured":"Klarin D, Natarajan P. Clinical utility of polygenic risk scores for coronary artery disease. Nat Rev Cardiol. 2022, 19:291-301. 10.1038\/s41569-021-00638-w","journal-title":"Nat Rev Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12687-023-00645-z","article-title":"Clinical utility of polygenic risk scores: a critical 2023 appraisal","volume":"14","author":"Koch S","year":"2023","unstructured":"Koch S, Schmidtke J, Krawczak M, Caliebe A. Clinical utility of polygenic risk scores: a critical 2023 appraisal. J Community Genet. 2023, 14:471-87. 10.1007\/s12687-023-00645-z","journal-title":"J Community Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-022-02452-x","article-title":"The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review","volume":"141","author":"Kumuthini J","year":"2022","unstructured":"Kumuthini J, Zick B, Balasopoulou A, et al.. The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review. Hum Genet. 2022, 141:1697-704. 10.1007\/s00439-022-02452-x","journal-title":"Hum Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02583-y","article-title":"Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease","volume":"20","author":"King A","year":"2022","unstructured":"King A, Wu L, Deng HW, Shen H, Wu C. Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease. BMC Med. 2022, 20:385. 10.1186\/s12916-022-02583-y","journal-title":"BMC Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae342","article-title":"Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting","volume":"45","author":"Samani NJ","year":"2024","unstructured":"Samani NJ, Beeston E, Greengrass C, et al.. Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting. Eur Heart J. 2024, 45:3152-60. 10.1093\/eurheartj\/ehae342","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2023-000554","article-title":"Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog","volume":"2","author":"Hingorani AD","year":"2023","unstructured":"Hingorani AD, Gratton J, Finan C, et al.. Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog. BMJ Med. 2023, 2:e000554. 10.1136\/bmjmed-2023-000554","journal-title":"BMJ Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","author":"Mega JL","year":"2015","unstructured":"Mega JL, Stitziel NO, Smith JG, et al.. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. Lancet. 2015, 385:2264-71. 10.1016\/S0140-6736(14)61730-X","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting","volume":"135","author":"Natarajan P","year":"2017","unstructured":"Natarajan P, Young R, Stitziel NO, et al.. Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting. Circulation. 2017, 135:2091-101. 10.1161\/CIRCULATIONAHA.116.024436","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020109","article-title":"Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial)","volume":"133","author":"Kullo IJ","year":"2016","unstructured":"Kullo IJ, Jouni H, Austin EE, et al..  Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial). Circulation. 2016, 133:1181-8. 10.1161\/CIRCULATIONAHA.115.020109","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.124.004968","article-title":"Effect of disclosing a polygenic risk score for coronary heart disease on adverse cardiovascular events","volume":"18","author":"Naderian M","year":"2025","unstructured":"Naderian M, Hamed ME, Vaseem AA, et al.. Effect of disclosing a polygenic risk score for coronary heart disease on adverse cardiovascular events. Circ Genom Precis Med. 2025, 18:e004968. 10.1161\/CIRCGEN.124.004968","journal-title":"Circ Genom Precis Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-314211","article-title":"Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial","volume":"105","author":"Silarova B","year":"2019","unstructured":"Silarova B, Sharp S, Usher-Smith JA, et al.. Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial. Heart. 2019, 105:982-9. 10.1136\/heartjnl-2018-314211","journal-title":"Heart"},{"key":"ref15","article-title":"Implementing polygenic scores for cardiovascular disease into NHS health checks","author":"Brigden T","year":"2021","unstructured":"Brigden T, Sanderson S, Janus J, Babb de Villiers C, Moorthie S, Kroese M, Hall A. Implementing polygenic scores for cardiovascular disease into NHS health checks. PHG Foundation, Cambridge; 2021."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11112-0","article-title":"Analysis of polygenic risk\u00a0score usage and performance in diverse human populations","volume":"10","author":"Duncan L","year":"2019","unstructured":"Duncan L, Shen H, Gelaye B, et al.. Analysis of polygenic risk\u00a0score usage and performance in diverse human populations. Nat Commun. 2019, 10:3328. 10.1038\/s41467-019-11112-0","journal-title":"Nat Commun"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin AR","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019, 51:584-91. 10.1038\/s41588-019-0379-x","journal-title":"Nat Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2020.04.002","article-title":"Predictive utility of polygenic risk scores for coronary heart disease in three major racial and ethnic groups","volume":"106","author":"Dikilitas O","year":"2020","unstructured":"Dikilitas O, Schaid DJ, Kosel ML, et al.. Predictive utility of polygenic risk scores for coronary heart disease in three major racial and ethnic groups. Am J Hum Genet. 2020, 106:707-16. 10.1016\/j.ajhg.2020.04.002","journal-title":"Am J Hum Genet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02429-x","article-title":"A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease","volume":"29","author":"Patel AP","year":"2023","unstructured":"Patel AP, Wang M, Ruan Y, et al.. A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease. Nat Med. 2023, 29:1793-803. 10.1038\/s41591-023-02429-x","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.122.003712","article-title":"Validation of polygenic risk scores for coronary heart disease in a Middle Eastern cohort using whole genome sequencing","volume":"15","author":"Saad M","year":"2022","unstructured":"Saad M, El-Menyar A, Kunji K, Ullah E, Al Suwaidi J, Kullo IJ. Validation of polygenic risk scores for coronary heart disease in a Middle Eastern cohort using whole genome sequencing. Circ Genom Precis Med. 2022, 15:e003712. 10.1161\/CIRCGEN.122.003712","journal-title":"Circ Genom Precis Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001304","article-title":"Direct-to-consumer genetic testing for cardiovascular disease: a scientific statement from the American Heart Association","volume":"151","author":"Hull LE","year":"2025","unstructured":"Hull LE, Aday AW, Bui QM, et al.. Direct-to-consumer genetic testing for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2025, 151:e905-17. 10.1161\/CIR.0000000000001304","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.881349","article-title":"Psychosocial effects of receiving genome-wide polygenic risk information concerning type 2 diabetes and coronary heart disease: a randomized controlled trial","volume":"13","author":"Halmesvaara O","year":"2022","unstructured":"Halmesvaara O, Vornanen M, K\u00e4\u00e4ri\u00e4inen H, Perola M, Kristiansson K, Konttinen H. Psychosocial effects of receiving genome-wide polygenic risk information concerning type 2 diabetes and coronary heart disease: a randomized controlled trial. Front Genet. 2022, 13:881349. 10.3389\/fgene.2022.881349","journal-title":"Front Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2025.05.012","article-title":"Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: a systematic review of economic evaluations","volume":"112","author":"Siena LM","year":"2025","unstructured":"Siena LM, Baccolini V, Riccio M, et al.. Weighing the evidence on costs and benefits of polygenic risk-based approaches in clinical practice: a systematic review of economic evaluations. Am J Hum Genet. 2025, 112:1735-53. 10.1016\/j.ajhg.2025.05.012","journal-title":"Am J Hum Genet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.121.003423","article-title":"Cost-effectiveness of polygenic risk scores to guide statin therapy for cardiovascular disease prevention","volume":"15","author":"Kiflen M","year":"2022","unstructured":"Kiflen M, Le A, Mao S, Lali R, Narula S, Xie F, Par\u00e9 G. Cost-effectiveness of polygenic risk scores to guide statin therapy for cardiovascular disease prevention. Circ Genom Precis Med. 2022, 15:e003423. 10.1161\/CIRCGEN.121.003423","journal-title":"Circ Genom Precis Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2024.100672","article-title":"Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - a system dynamics model","volume":"18","author":"Vernon ST","year":"2024","unstructured":"Vernon ST, Brentnall S, Currie DJ, et al.. Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease - a system dynamics model. Am J Prev Cardiol. 2024, 18:100672. 10.1016\/j.ajpc.2024.100672","journal-title":"Am J Prev Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1139496","article-title":"Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program","volume":"11","author":"Mujwara D","year":"2023","unstructured":"Mujwara D, Kintzle J, Di Domenico P, Busby GB, Bott\u00e0 G. Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program. Front Public Health. 2023, 11:1139496. 10.3389\/fpubh.2023.1139496","journal-title":"Front Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/512624-polygenic-risk-scores-in-cardiovascular-prevention-clinical-promise-implementation-challenges-and-genomic-risk-stewardship","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:10:57Z","timestamp":1783937457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/512624-polygenic-risk-scores-in-cardiovascular-prevention-clinical-promise-implementation-challenges-and-genomic-risk-stewardship"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.112566","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}